Stocks analysis

ABBV vs ADI Stock Comparison

Scores Breakdown

Metric ABBV ADI
📈 Growth 15/30 28/30
💰 Profitability 16/20 18/20
🏦 Financial Health 12/20 19/20
💵 Valuation 12/20 12/20
⚠️ Risk (lower is better) 6/10 4/10
Overall Score 59/100 83/100

Side-by-Side Summaries

ABBV Analysis ADI Analysis

📈 Growth & Financial Trajectory

8 quarters show a largely rising topline: 2024Q1 to 2026Q1 Revenues rise from about $12.31B to $15.00B (+≈22%). Net income attributable to parent falls from ~$1.29B to ~$0.70B, though peaks around ~$1.86B in 2025Q2–Q3, with 2025Q4 at ~$1.82B. The trend is mixed: topline strength persists, but bottom-line profitability weakens into 2026Q1.

💰 Margins & Cash Flow

Gross margins remain high, broadly ~70–79%, reflecting a durable product mix. Operating leverage remains healthy as volumes expand. Net cash flow from operating activities stays robust, typically around $5.1B–$5.3B per quarter; investing activity is negative (capex/activity), and financing flows cause periodic swings.

🛡️ Balance Sheet & Liquidity

Total assets hover near the mid-to-upper hundreds of billions with liabilities that verge on or exceed assets in some periods, and equity attributable to the parent is often negative (reflecting buybacks). The firm generates solid operating cash flow that supports liquidity despite leverage. Long-term debt runs in the mid-$60B range in recent periods, with current liabilities ~$39–$44B.

⚠️ Key Drivers & Risks

  • Drivers: Robust pharma demand and a durable high-margin mix; ongoing pipeline progress.
  • Risks: Patent/regulatory pressures; elevated leverage and sensitivity to interest rates; potential valuation volatility.

📈 Growth & Financial Trajectory

Across eight quarters from 2024 Q3 to 2026 Q2, ANALOG DEVICES INC shows a steady top-line expansion: Revenues rise from about $2.31B to $3.62B, a ~56% gain. Net income climbs from ~$392M to ~$1,176M, up ~200%, signaling improving operating leverage as volumes scale. The trend is predominantly upward, with performance stepping higher into 2025–2026, culminating in a strong Q2 2026 print.

💰 Margins & Cash Flow

Gross margin remains robust in the mid-50s to mid-60s percent range, supported by mix and pricing. Operating leverage improves as fixed costs amortize with volume. Operating cash flow is consistently positive; Net cash flow fluctuates due to financing activities, with Q2 2026 showing a negative quarterly net cash flow despite solid operating cash generation. Investing cash flow is modestly negative, while financing activity fluctuations drive quarterly cash flow swings.

🛡️ Balance Sheet & Liquidity

Equity attributable to parent sits around the low-$30B level; Liabilities total roughly mid-$14B, with current assets near $5–7B and current liabilities around $3–4B, giving a healthy current ratio and ample liquidity cushion. The balance sheet shows strong equity, manageable leverage, and a solid asset base.

⚠️ Key Drivers & Risks

  • Drivers: AI/data-center demand; automotive and industrial sensors.
  • Risks: Semiconductor cyclicality; macro shifts and valuation sensitivity.